These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14576921)

  • 1. [Wasting syndrome in cancer patients: pathophysiology, clinical manifestations and drug therapy].
    Ferriols Lisart F; Tordera Baviera M
    Farm Hosp; 2003; 27(5):308-16. PubMed ID: 14576921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cancer anorexia-cachexia syndrome.
    Nelson KA
    Semin Oncol; 2000 Feb; 27(1):64-8. PubMed ID: 10697022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent development in research and management of cancer anorexia-cachexia syndrome].
    Inui A
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):743-9. PubMed ID: 15984510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global dysregulation:the foundation of involuntary weight loss in cancer patients.
    J Support Oncol; 2006 Feb; 4(2):89-90. PubMed ID: 16499132
    [No Abstract]   [Full Text] [Related]  

  • 5. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
    Jatoi A; Rowland K; Loprinzi CL; Sloan JA; Dakhil SR; MacDonald N; Gagnon B; Novotny PJ; Mailliard JA; Bushey TI; Nair S; Christensen B;
    J Clin Oncol; 2004 Jun; 22(12):2469-76. PubMed ID: 15197210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing end points and outcomes in cancer-associated wasting.
    Dahele M; Wall L
    J Clin Oncol; 2005 Apr; 23(12):2871-2; author reply 2872-3. PubMed ID: 15838010
    [No Abstract]   [Full Text] [Related]  

  • 7. The energetics of wasting diseases.
    Kulstad R; Schoeller DA
    Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):488-93. PubMed ID: 17563468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological approaches to ameliorating catabolic conditions.
    Elamin EM; Glass M; Camporesi E
    Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):449-54. PubMed ID: 16778575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approaches in an integrated therapy of inflammatory-associated wasting in end-stage renal disease.
    Stenvinkel P; Lindholm B; Heimbürger O
    Semin Dial; 2004; 17(6):505-15. PubMed ID: 15660582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Feeding-related disorders in medicine, with special reference to cancer anorexia-cachexia syndrome].
    Inui A
    Rinsho Byori; 2006 Oct; 54(10):1044-51. PubMed ID: 17133993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptophan in wasting diseases: at the crossing between immune function and behaviour.
    Laviano A; Meguid MM; Cascino A; Molfino A; Rossi Fanelli F
    Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):392-7. PubMed ID: 19465846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism and novel therapeutic approaches to wasting in chronic disease.
    Ebner N; Springer J; Kalantar-Zadeh K; Lainscak M; Doehner W; Anker SD; von Haehling S
    Maturitas; 2013 Jul; 75(3):199-206. PubMed ID: 23664695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ghrelin and ghrelin analogues in wasting disease.
    Kamiji MM; Inui A
    Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):443-51. PubMed ID: 18542005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and wasting in cancer.
    Laviano A; Meguid MM; Preziosa I; Rossi Fanelli F
    Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):449-56. PubMed ID: 17563463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy insight: Cancer anorexia-cachexia syndrome--when all you can eat is yourself.
    Laviano A; Meguid MM; Inui A; Muscaritoli M; Rossi-Fanelli F
    Nat Clin Pract Oncol; 2005 Mar; 2(3):158-65. PubMed ID: 16264909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral salt wasting syndrome following neurosurgical intervention in tuberculous meningitis.
    Nagotkar L; Shanbag P; Dasarwar N
    Indian Pediatr; 2008 Jul; 45(7):598-601. PubMed ID: 18695284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of body composition measurements in wasting syndromes.
    Koch J
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):12-9. PubMed ID: 9625378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer and acquired immunodeficiency syndrome wasting syndromes: current and future therapies.
    Bunn PA
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):1-3. PubMed ID: 9625376
    [No Abstract]   [Full Text] [Related]  

  • 20. Alterations in glucose metabolism in non-endocrine disease: potential implication for wasting.
    Sauerwein HP; Romijn JA
    Clin Nutr; 2001 Feb; 20(1):2-8. PubMed ID: 11161536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.